DE60224215D1 - Herstellungsverfahren einer interaktionverbindung von wirkstoffen mit einem porösen träger durch ein überkritisches fluidum - Google Patents

Herstellungsverfahren einer interaktionverbindung von wirkstoffen mit einem porösen träger durch ein überkritisches fluidum

Info

Publication number
DE60224215D1
DE60224215D1 DE60224215T DE60224215T DE60224215D1 DE 60224215 D1 DE60224215 D1 DE 60224215D1 DE 60224215 T DE60224215 T DE 60224215T DE 60224215 T DE60224215 T DE 60224215T DE 60224215 D1 DE60224215 D1 DE 60224215D1
Authority
DE
Germany
Prior art keywords
fluidum
crucible
manufacturing
supercritical fluid
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60224215T
Other languages
English (en)
Other versions
DE60224215T2 (de
Inventor
Bernard Freiss
Florence Marciacq
Jacques Fages
Martial Sauceau
Hubert Lochard
Jean-Jacques Letourneau
Christophe Joussot-Dubien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE60224215D1 publication Critical patent/DE60224215D1/de
Publication of DE60224215T2 publication Critical patent/DE60224215T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)
DE60224215T 2001-10-12 2002-10-11 Herstellungsverfahren einer interaktionverbindung von wirkstoffen mit einem porösen träger durch ein überkritisches fluidum Expired - Lifetime DE60224215T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0113178A FR2830760B1 (fr) 2001-10-12 2001-10-12 Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique
FR0113178 2001-10-12
PCT/FR2002/003474 WO2003043604A1 (fr) 2001-10-12 2002-10-11 Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique

Publications (2)

Publication Number Publication Date
DE60224215D1 true DE60224215D1 (de) 2008-01-31
DE60224215T2 DE60224215T2 (de) 2008-12-04

Family

ID=8868228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60224215T Expired - Lifetime DE60224215T2 (de) 2001-10-12 2002-10-11 Herstellungsverfahren einer interaktionverbindung von wirkstoffen mit einem porösen träger durch ein überkritisches fluidum

Country Status (18)

Country Link
US (1) US7390411B2 (de)
EP (1) EP1434567B1 (de)
JP (1) JP4401778B2 (de)
CN (1) CN100396277C (de)
AT (1) ATE381318T1 (de)
AU (1) AU2002361279B2 (de)
BR (2) BR0213220A (de)
CA (1) CA2462537C (de)
CY (1) CY1107306T1 (de)
DE (1) DE60224215T2 (de)
DK (1) DK1434567T3 (de)
ES (1) ES2295446T3 (de)
FR (1) FR2830760B1 (de)
HK (1) HK1087019A1 (de)
MX (1) MXPA04003300A (de)
PT (1) PT1434567E (de)
WO (1) WO2003043604A1 (de)
ZA (1) ZA200402580B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854079B1 (fr) * 2003-04-25 2007-11-30 Pf Medicament Procede de preparation de complexes moleculaires
ATE504316T1 (de) * 2004-04-01 2011-04-15 Pf Medicament Einschlusskomplexe enthaltend piroxicam, ein cyklodextrin und arginin
FR2868315B1 (fr) * 2004-04-01 2006-07-14 Pierre Fabre Medicament Sa Procede de preparation d'un compose d'inclusion soluble de substances actives dans une molecule hote avec l'aide d'un agent d'interaction par fluide supercritique
FR2876910B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction
FR2876914A1 (fr) * 2004-10-21 2006-04-28 Pierre Fabre Medicament Sa Complexe comprenant un antibiotique, une cyclodextrine et un agent d'interaction
ITSA20050008A1 (it) * 2005-03-10 2006-09-11 Univ Degli Studi Salerno Processo per la produzione di membrane caricate con uno o piu' principi attivi
ATE466065T1 (de) * 2006-02-10 2010-05-15 Carotech Sdn Bhd Verfahren zur gewinnung hochangereicherter naturstoff-fraktionen aus palmöl unter verwendung von superkritischen und beinahe superkritischen flüssigmedien
FR2944280B1 (fr) 2009-04-09 2012-08-03 Galderma Res & Dev Procede de preparation de complexes moleculaires entre adapalene et des cyclodextrines
FR2944207B1 (fr) * 2009-04-09 2011-05-06 Galderma Res & Dev Compositions comprenant au moins un complexe compose d'un derive d'acide naphtoique et d'au moins une cyclodestrine et leurs utilisations
WO2012145631A1 (en) * 2011-04-22 2012-10-26 Pepsico, Inc. Encapsulation of extract in porous particles
EP2884523B1 (de) * 2013-12-16 2020-02-05 IMEC vzw Verfahren zum Aktivieren einer porösen Schichtoberfläche
CN105343893B (zh) * 2015-12-11 2018-07-20 中国药科大学 对乙酰氨基酚-2-羟丙基-β-环糊精包合物制备方法
WO2017118266A1 (en) * 2016-01-08 2017-07-13 Chen Shing-Jye Acellular corneas, methods of producing the same and uses thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US189454A (en) * 1877-04-10 Improvement in paper boxes
GB2191715B (en) 1986-06-17 1990-07-25 Midrex Int Bv Method and apparatus for dedusting and desulfurizing gases
JPH0677511B2 (ja) * 1986-12-05 1994-10-05 金印わさび株式会社 香辛成分の包接化合物の製造方法
US4822497A (en) * 1987-09-22 1989-04-18 Modar, Inc. Method for solids separation in a wet oxidation type process
DE3744329A1 (de) * 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
FR2629735B1 (fr) * 1988-04-11 1991-03-22 Agronomique Inst Nat Rech Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus
GB9100643D0 (en) 1991-01-11 1991-02-27 Shaffery Michael J Filter system
US5389263A (en) * 1992-05-20 1995-02-14 Phasex Corporation Gas anti-solvent recrystallization and application for the separation and subsequent processing of RDX and HMX
DE59406065D1 (de) * 1993-03-24 1998-07-02 Ciba Geigy Ag Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
EP0706821A1 (de) 1994-10-06 1996-04-17 Centre De Microencapsulation Verfahren zum Beschichten von Partikeln
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
JP3986086B2 (ja) 1996-03-01 2007-10-03 ザ ユニバーシティ オブ カンザス 近臨界および超臨界反溶媒を用いる粒子析出方法および被覆方法
FR2753639B1 (fr) * 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
DE19711393C1 (de) 1997-03-19 1998-08-13 Fraunhofer Ges Forschung Verfahren zum Mikroverkapseln von Partikeln
IT1296464B1 (it) 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
GB9810559D0 (en) 1998-05-15 1998-07-15 Bradford Particle Design Ltd Method and apparatus for particle formation
GB9824298D0 (en) 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
SE9804001D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New process
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
CN1280875A (zh) * 1999-06-30 2001-01-24 刘士群 用超临界反萃剂制造微粒的方法和装置
FR2798863B1 (fr) * 1999-09-27 2001-12-28 Separex Sa Procede et installation de mise a l'etat adsorbe sur un support poreux de composes actifs contenus dans un produit
FR2799984B1 (fr) 1999-10-21 2002-05-03 Lavipharm Procede de fractionnement d'une matiere composee de plusieurs constituants a l'aide d'un solvant a pression supercritique
FR2803538B1 (fr) 1999-12-15 2002-06-07 Separex Sa Procede et dispositif de captage de fines particules par percolation dans un lit de granules
FR2815540B1 (fr) * 2000-10-19 2005-06-10 Separex Sa Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote
US6896905B2 (en) * 2001-02-15 2005-05-24 Rohm And Haas Company Porous particles, their aqueous dispersions, and method of preparation
WO2002089851A1 (fr) 2001-03-06 2002-11-14 Separex (Societe Anonyme) Procede de fabrication de complexes hote-client

Also Published As

Publication number Publication date
CN1713894A (zh) 2005-12-28
JP4401778B2 (ja) 2010-01-20
BR0213220A (pt) 2004-08-31
ES2295446T3 (es) 2008-04-16
CN100396277C (zh) 2008-06-25
PT1434567E (pt) 2008-02-08
US7390411B2 (en) 2008-06-24
FR2830760A1 (fr) 2003-04-18
HK1087019A1 (en) 2006-10-06
DE60224215T2 (de) 2008-12-04
ZA200402580B (en) 2004-11-04
BRPI0213220B1 (pt) 2018-09-18
CY1107306T1 (el) 2012-11-21
WO2003043604A1 (fr) 2003-05-30
JP2005512621A (ja) 2005-05-12
US20050274671A1 (en) 2005-12-15
CA2462537C (fr) 2011-06-21
EP1434567B1 (de) 2007-12-19
AU2002361279A1 (en) 2003-06-10
FR2830760B1 (fr) 2004-06-04
CA2462537A1 (fr) 2003-05-30
ATE381318T1 (de) 2008-01-15
MXPA04003300A (es) 2004-07-23
DK1434567T3 (da) 2008-05-05
AU2002361279B2 (en) 2007-02-08
EP1434567A1 (de) 2004-07-07

Similar Documents

Publication Publication Date Title
CY1107306T1 (el) Μεθοδος παρασκευης μιας ενωσεως αλληλεπιδρασεως δραστικων ουσιων με ενα πορωδες υποστρωμα μεσω ενος υπερκρισιμου ρευστου
Koehler et al. A generalized view of foam drainage: experiment and theory
Hibara et al. Surface modification method of microchannels for gas− liquid two-phase flow in microchips
US6883559B2 (en) Method and apparatus for gradient generation
Slentz et al. Nanoliter capillary electrochromatography columns based on collocated monolithic support structures molded in poly (dimethyl siloxane)
CN105363503B (zh) 多组分微液滴微流控芯片及其加工方法
AU2002213423A1 (en) Method and apparatus for gradient generation
WO2004018066A3 (en) Aqueous two-phase systems for particle manipulation and encapsulation within microscopic volumes
DK1214058T3 (da) Fremgangsmåde til opnåelse af mikorpartikler
EP1391507A4 (de) Vorrichtung und verfahren zur reinigung von nukleinsäure
Miyazaki et al. Preparation of functionalized nanostructures on microchannel surface and their use for enzyme microreactors
AR011716A1 (es) Una particula efervescente, anhidra, substancialmente , de 75 micrones-2 cm. composicion detergente que la comprende. proceso de fabricacion. metodode lavado
Rozenski et al. Overview of in‐capillary enzymatic reactions using capillary electrophoresis
WO2003030867A3 (fr) Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique
ATE280195T1 (de) Acrylschaum druckempfindliche klebstoffe und herstellungsverfahren
CN103374343A (zh) 调剖驱油用吸水膨胀材料及其生产方法
CN103232613A (zh) 双亲性寡肽对聚甲基丙烯酸甲酯微流控芯片表面改性方法
JP2009072649A (ja) ナノバブル溶液、ナノバブル溶液を製造する方法及び装置、ナノバブル溶液の利用方法
ATE368451T1 (de) Verfahren zum überziehen von feststoffteilchen
DK1401404T3 (da) Fremgangsmåde til indkapsling af et aktivt stof
CN108836353A (zh) 一种油/油汗混合型指纹显现方法
CN207294321U (zh) 一种膜生物反应器
ATE300594T1 (de) Mulchmethode
Wang et al. Normal-phase HPLC enantioseparation of novel chiral metal tetrahedrane-type clusters on an amylose-based chiral stationary phase
KR970013080A (ko) 불산(hf)용액을 사용한 습식세정시 파티를 감소방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition